Genomic Unity® Endocrinology Analysis

EA001

Genomic Unity® Endocrinology Analysis is a diagnostic test designed to identify genetic variants that cause endocrine disorders.

Test Description

Genomic Unity® Endocrinology Analysis is a targeted test that uses a whole genome platform to detect all major clinically relevant variant types from a single sample. This targeted test focuses on 280 genes associated with endocrine disorders.

Genomic Unity® Endocrinology Analysis provides a single, unified clinical report that replaces a battery of tests including: multiplex ligation dependent probe amplification (MLPA) and single gene or targeted gene panel testing.

When to Order

Order this test when clinical symptoms are consistent with a suspected genetic endocrine disorder.

Included Genes

ABCA1, ABCC8, ABCD1, ABCG5, ABCG8, ACAT1, ACSF3, ACTN4, ADCY3, AFF3, AGL, AIRE, ALDOA, ALDOB, ALMS1, AMH, AMHR2, ANOS1, AP2S1, APOA1, APOA5, APOB, APOC2, APOC3, APOE, AQP2, AR, ARL6, ARMC5, ARX, ATRX, AVPR2, BBIP1, BBS1, BBS2, BBS4, BBS5, BBS7, BBS9, BBS10, BBS12, BCOR, BLK, BMP15, BSND, CASR, CCDC28B, CDC73, CDKN1A, CDKN1B, CDKN1C, CDKN2B, CDKN2C, CEL, CEP41, CEP290, CHD7, CLCNKB, CLDN16, CLDN19, CNNM2, CNNM4, COL1A1, COL1A2, CREB3L3, CREBBP, CUL4B, CYP11A1, CYP11B1, CYP17A1, CYP19A1, DHCR7, DHH, DUOX2, DUOXA2, DUSP6, DYNC2H1, DYRK1B, EGF, EIF2AK3, ENO3, EPM2A, ERCC3, ETFA, ETFB, ETFDH, FBP1, FEZF1, FGF8, FGF17, FGF23, FGFR1, FIG4, FLRT3, FOXE1, FOXL2, FOXP3, FRAS1, FSHB, FSHR, FXYD2, G6PC, G6PC2, GAA, GALT, GATA4, GATA6, GBE1, GCK, GCM2, GH1, GHR, GLIS3, GLUD1, GNA11, GNAS, GNRH1, GNRHR, GPIHBP1, GYG1, GYS1, GYS2, HADH, HESX1, HMGCL, HMGCS2, HNF1A, HNF1B, HNF4A, HS6ST1, HSD3B2, HSD11B2, HSD17B3, IFT27, IGSF1, IL17RD, INF2, INS, INSR, IRF6, KCNA1, KCNJ10, KCNJ11, KISS1, KISS1R, KLF11, KRAS, KSR2, LAMB2, LAMP2, LDHA, LDLR, LDLRAP1, LEPR, LHB, LHCGR, LIPA, LMF1, LMNA, LPL, LRP5, LZTFL1, MAGEL2, MAGT1, MAMLD1, MAP3K1, MC2R, MC3R, MEN1, MKKS, MKRN3, MKS1, MPV17, MRAP, NEUROD1, NEUROG3, NF1, NHLRC1, NIPA2, NKX2-1, NKX2-2, NKX2-5, NNT, NOBOX, NPHS1, NPHS2, NR0B1, NR0B2, NR3C1, NR5A1, NSMF, NTRK2, OXCT1, PAX4, PAX8, PC, PCBD1, PCK1, PCSK1, PCSK9, PDX1, PFKM, PGAM2, PGK1, PGM1, PHEX, PHF6, PHKA1, PHKA2, PHKB, PKD1, PKD2, PLCE1, POLG, POMC, PORCN, POU1F1, PPARG, PRKAG2, PRKAG3, PRKAR1A, PROK2, PROKR2, PROP1, PTF1A, PTH, PTPN11, PYGL, PYGM, RAF1, RBCK1, RET, RFX6, RSPO1, SARS2, SCNN1A, SCNN1B, SCNN1G, SDCCAG8, SDHB, SECISBP2, SEMA3A, SEMA3E, SHOX, SIM1, SLC2A2, SLC5A5, SLC12A3, SLC16A1, SLC16A2, SLC26A4, SLC37A4, SOS1, SOX9, SPRY4, SRD5A2, SRY, STAR, TAC3, TACR3, TG, THRA, THRB, TPO, TRIM32, TRPC6, TRPM6, TSHB, TSHR, TTC8, UCP2, UCP3, VHL, VPS13B, WDPCP, WDR11, WFS1, WT1, ZFP57, ZFPM2

Included Analyses

  • Sequence analysis of endocrine disorder-associated genes including: single nucleotide variants, deletions, insertions, and characterized intronic variants.
  • Copy number variant analysis of endocrine disorder-associated genes including: duplications/deletions, mobile element insertions, and inversions.

Optionally includes:

Turnaround Time

A report will be issued within 4 weeks. Turnaround time begins when samples and all required documents and approvals are received.

Sample Types

CPT Codes

81173, 81250, 81401, 81403, 81404, 81405, 81406, 81407, 81408, 81443, 81479

The CPT codes provided are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Methods and Limitations

Genomic Unity® Endocrinology Analysis uses a PCR-free whole genome sequencing (WGS) platform paired with our Genomic Intelligence® analytical software.

SNVs:
>99.9% sensitivity
>99.9% specificity
>99.8% positive predictive value

Structural variants:
96% clinical sensitivity

Test limitations:
The AR, ARX, INF2 and LRP5 genes are not fully covered by this test, therefore not all pathogenic variants may be detected. The CEL and SHOX genes contain regions that are non-unique, therefore not all variants can be assigned to the correct location, limiting interpretation.